Using Ultrasound to Predict Response to Intraarticular Corticosteroids in Knee Osteoarthritis

NCT ID: NCT00746889

Last Updated: 2010-08-25

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

79 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-03-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study using characteristics on ultrasound to predict response to intraarticular steroid injections in patients with knee osteoarthritis. The hypothesis is that patients with inflammation on ultrasound will have a better response to corticosteroid injections compared to patients without inflammation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Corticosteroid Injection

40 mg of intraarticular triamcinolone acetonide

Group Type ACTIVE_COMPARATOR

triamcinolone acetonide

Intervention Type DRUG

single intraarticular injection of 40 mg of triamcinolone acetonide

Placebo Injection

Intraarticular injection of 0.9% saline

Group Type PLACEBO_COMPARATOR

saline

Intervention Type DRUG

Single intraarticular injection of 1 ml of 0.9% saline

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

triamcinolone acetonide

single intraarticular injection of 40 mg of triamcinolone acetonide

Intervention Type DRUG

saline

Single intraarticular injection of 1 ml of 0.9% saline

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* knee pain
* diagnosis of osteoarthritis in affected knee

Exclusion Criteria

* intraarticular corticosteroids in affected knee within past three months
* primary inflammatory connective tissue disease (ie rheumatoid arthritis)
* currently taking oral corticosteroids
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Diego

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of California San Diego

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kenneth Kalunian, MD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Diego

Anna Quan, MD

Role: STUDY_CHAIR

San Diego VA Hospital

Michal Kalli Hose, MD

Role: STUDY_DIRECTOR

San Diego VA Hospital

Jeannie Chao, MD

Role: STUDY_DIRECTOR

University of California, San Diego

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California San Diego Medical Center

La Jolla, California, United States

Site Status

San Diego VA Hospital

La Jolla, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB 051420

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.